Trial Profile
Phase 2 study of ACY-241 in patients with multiple myeloma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 11 May 2017
Price :
$35
*
At a glance
- Drugs Citarinostat (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 08 Jun 2016 New trial record